芬太尼含片不同给药方案在日本健康志愿者体内的相对生物利用度

Mona Darwish PhD, Kenneth Tempero MD, PhD, John G. Jiang PhD, Philip G. Simonson PhD
{"title":"芬太尼含片不同给药方案在日本健康志愿者体内的相对生物利用度","authors":"Mona Darwish PhD,&nbsp;Kenneth Tempero MD, PhD,&nbsp;John G. Jiang PhD,&nbsp;Philip G. Simonson PhD","doi":"10.1111/j.1753-5174.2008.00009.x","DOIUrl":null,"url":null,"abstract":"<p><b>Background. </b> Fentanyl buccal tablet (FBT; <i>FENTORA</i><sup>®</sup>, Cephalon, Inc., Frazer, PA, USA) is indicated in the US for breakthrough pain in patients with cancer who are already receiving and are tolerant to around-the-clock opioid therapy for underlying persistent cancer pain. For each individual patient, FBT should be titrated to the effective dose.</p><p><b>Objective. </b> The primary objective was to characterize the pharmacokinetic parameters of FBT 400 µg administered as a single 400 µg tablet (regimen A) or as two 200 µg tablets given simultaneously (regimen B) and determine whether these are bioequivalent in healthy Japanese volunteers. Regimen C (two 200 µg tablets 30 minutes apart) was also compared as a secondary objective.</p><p><b>Methods. </b> Healthy Japanese adults received regimens A, B, and C in a crossover fashion. Naltrexone was given to minimize the opioid effects of fentanyl. Serum fentanyl concentrations were determined in venous blood collected through 36 hours post dose. Regimens were declared bioequivalent with respect to bioavailability (as reflected by AUC<sub>0–∞</sub>, AUC<sub>0–last</sub>, and C<sub>max</sub>) if the 90% confidence interval (CI) of the regimens' ratio fell within 0.80–1.25 (80%–125%).</p><p><b>Results. </b> Twenty-nine volunteers (13 men, 16 women) were enrolled; 24 completed the study. Regimens A and B had bioequivalent systemic exposure parameters (B/A [90% CI]: AUC<sub>0–∞</sub>108.4 [103.4, 113.7], AUC<sub>0–last</sub> 106.1 [100.7, 111.7], and C<sub>max</sub> 92.3 [83.2, 102.4]). Regimen C was bioequivalent to both A and B for AUCs, but only to B for C<sub>max</sub>. Median time to C<sub>max</sub> was 45 minutes for regimen A and 60 minutes for regimens B and C. The most frequent AEs were dizziness, application-site erythema, headache, somnolence, nausea, and vomiting. All AEs were mild or moderate.</p><p><b>Conclusions. </b> Bioavailability of fentanyl after FBT 400 µg administered as a single tablet was bioequivalent to that after 2 simultaneously administered 200 µg tablets in healthy Japanese volunteers. AEs were mild or moderate.</p>","PeriodicalId":8181,"journal":{"name":"Archives of Drug Information","volume":"1 2","pages":"56-62"},"PeriodicalIF":0.0000,"publicationDate":"2008-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/j.1753-5174.2008.00009.x","citationCount":"2","resultStr":"{\"title\":\"Relative Bioavailability of Fentanyl Following Various Dosing Regimens of Fentanyl Buccal Tablet in Healthy Japanese Volunteers\",\"authors\":\"Mona Darwish PhD,&nbsp;Kenneth Tempero MD, PhD,&nbsp;John G. Jiang PhD,&nbsp;Philip G. Simonson PhD\",\"doi\":\"10.1111/j.1753-5174.2008.00009.x\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><b>Background. </b> Fentanyl buccal tablet (FBT; <i>FENTORA</i><sup>®</sup>, Cephalon, Inc., Frazer, PA, USA) is indicated in the US for breakthrough pain in patients with cancer who are already receiving and are tolerant to around-the-clock opioid therapy for underlying persistent cancer pain. For each individual patient, FBT should be titrated to the effective dose.</p><p><b>Objective. </b> The primary objective was to characterize the pharmacokinetic parameters of FBT 400 µg administered as a single 400 µg tablet (regimen A) or as two 200 µg tablets given simultaneously (regimen B) and determine whether these are bioequivalent in healthy Japanese volunteers. Regimen C (two 200 µg tablets 30 minutes apart) was also compared as a secondary objective.</p><p><b>Methods. </b> Healthy Japanese adults received regimens A, B, and C in a crossover fashion. Naltrexone was given to minimize the opioid effects of fentanyl. Serum fentanyl concentrations were determined in venous blood collected through 36 hours post dose. Regimens were declared bioequivalent with respect to bioavailability (as reflected by AUC<sub>0–∞</sub>, AUC<sub>0–last</sub>, and C<sub>max</sub>) if the 90% confidence interval (CI) of the regimens' ratio fell within 0.80–1.25 (80%–125%).</p><p><b>Results. </b> Twenty-nine volunteers (13 men, 16 women) were enrolled; 24 completed the study. Regimens A and B had bioequivalent systemic exposure parameters (B/A [90% CI]: AUC<sub>0–∞</sub>108.4 [103.4, 113.7], AUC<sub>0–last</sub> 106.1 [100.7, 111.7], and C<sub>max</sub> 92.3 [83.2, 102.4]). Regimen C was bioequivalent to both A and B for AUCs, but only to B for C<sub>max</sub>. Median time to C<sub>max</sub> was 45 minutes for regimen A and 60 minutes for regimens B and C. The most frequent AEs were dizziness, application-site erythema, headache, somnolence, nausea, and vomiting. All AEs were mild or moderate.</p><p><b>Conclusions. </b> Bioavailability of fentanyl after FBT 400 µg administered as a single tablet was bioequivalent to that after 2 simultaneously administered 200 µg tablets in healthy Japanese volunteers. AEs were mild or moderate.</p>\",\"PeriodicalId\":8181,\"journal\":{\"name\":\"Archives of Drug Information\",\"volume\":\"1 2\",\"pages\":\"56-62\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2008-09-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1111/j.1753-5174.2008.00009.x\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Archives of Drug Information\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/j.1753-5174.2008.00009.x\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Drug Information","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/j.1753-5174.2008.00009.x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

摘要

背景。芬太尼含片;FENTORA®,Cephalon, Inc, Frazer, PA, USA)在美国适用于已经接受并耐受阿片类药物治疗潜在持续性癌症疼痛的癌症患者的突破性疼痛。对每个个体患者,应将FBT滴定至有效剂量。主要目的是表征400µg FBT作为单片400µg(方案a)或同时给予2片200µg(方案B)的药代动力学参数,并确定它们在健康的日本志愿者中是否具有生物等效性。方案C(200µg两片,间隔30分钟)也作为次要目标进行比较。健康的日本成年人以交叉方式接受方案A、B和C。给纳曲酮是为了尽量减少芬太尼的阿片效应。在给药后36小时采集静脉血,测定血清芬太尼浓度。如果方案比值的90%置信区间(CI)在0.80-1.25(80%-125%)之间,则方案在生物利用度方面(由AUC0 -∞、AUC0 - last和Cmax反映)被宣布为生物等效。招募了29名志愿者(13名男性,16名女性);24人完成了这项研究。方案A和方案B具有生物等效的全身暴露参数(B/A [90% CI]: AUC0 -∞108.4 [103.4,113.7],AUC0 - last 106.1 [100.7, 111.7], Cmax 92.3[83.2, 102.4])。对于auc,方案C与A和B生物等效,但对于Cmax,方案C仅与B生物等效。方案A达到Cmax的中位时间为45分钟,方案B和方案c为60分钟。最常见的ae为头晕、应用部位红斑、头痛、嗜睡、恶心和呕吐。所有ae均为轻度或中度。在健康的日本志愿者中,单片服用400µg芬太尼的生物利用度与同时服用2片200µg芬太尼的生物利用度相当。ae为轻度或中度。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Relative Bioavailability of Fentanyl Following Various Dosing Regimens of Fentanyl Buccal Tablet in Healthy Japanese Volunteers

Background. Fentanyl buccal tablet (FBT; FENTORA®, Cephalon, Inc., Frazer, PA, USA) is indicated in the US for breakthrough pain in patients with cancer who are already receiving and are tolerant to around-the-clock opioid therapy for underlying persistent cancer pain. For each individual patient, FBT should be titrated to the effective dose.

Objective. The primary objective was to characterize the pharmacokinetic parameters of FBT 400 µg administered as a single 400 µg tablet (regimen A) or as two 200 µg tablets given simultaneously (regimen B) and determine whether these are bioequivalent in healthy Japanese volunteers. Regimen C (two 200 µg tablets 30 minutes apart) was also compared as a secondary objective.

Methods. Healthy Japanese adults received regimens A, B, and C in a crossover fashion. Naltrexone was given to minimize the opioid effects of fentanyl. Serum fentanyl concentrations were determined in venous blood collected through 36 hours post dose. Regimens were declared bioequivalent with respect to bioavailability (as reflected by AUC0–∞, AUC0–last, and Cmax) if the 90% confidence interval (CI) of the regimens' ratio fell within 0.80–1.25 (80%–125%).

Results. Twenty-nine volunteers (13 men, 16 women) were enrolled; 24 completed the study. Regimens A and B had bioequivalent systemic exposure parameters (B/A [90% CI]: AUC0–∞108.4 [103.4, 113.7], AUC0–last 106.1 [100.7, 111.7], and Cmax 92.3 [83.2, 102.4]). Regimen C was bioequivalent to both A and B for AUCs, but only to B for Cmax. Median time to Cmax was 45 minutes for regimen A and 60 minutes for regimens B and C. The most frequent AEs were dizziness, application-site erythema, headache, somnolence, nausea, and vomiting. All AEs were mild or moderate.

Conclusions. Bioavailability of fentanyl after FBT 400 µg administered as a single tablet was bioequivalent to that after 2 simultaneously administered 200 µg tablets in healthy Japanese volunteers. AEs were mild or moderate.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Epoetin Theta with a New Dosing Schedule in Anaemic Cancer Patients Receiving Nonplatinum-Based Chemotherapy: A Randomised Controlled Trial Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD4877 in Japanese Patients with Solid Tumors Is Ciprofloxacin a Substrate of P-glycoprotein? Hydrocortisone Diffusion Through Synthetic Membrane, Mouse Skin, and Epiderm™ Cultured Skin. The Dose Proportionality of Telcagepant after Administration of Single Oral and Intravenous Doses in Healthy Adult Subjects
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1